Search by Drug Name or NDC

    NDC 63459-0601-06 Trisenox 2 mg/mL Details

    Trisenox 2 mg/mL

    Trisenox is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cephalon, LLC. The primary component is ARSENIC TRIOXIDE.

    Product Information

    NDC 63459-0601
    Product ID 63459-601_c6f1760b-1b0a-4e85-bdb5-b5554ba302d3
    Associated GPIs 21700008102030
    GCN Sequence Number 077987
    GCN Sequence Number Description arsenic trioxide VIAL 12 MG/6 ML INTRAVEN
    HIC3 V1F
    HIC3 Description ANTINEOPLASTICS,MISCELLANEOUS
    GCN 44165
    HICL Sequence Number 021734
    HICL Sequence Number Description ARSENIC TRIOXIDE
    Brand/Generic Brand
    Proprietary Name Trisenox
    Proprietary Name Suffix n/a
    Non-Proprietary Name Arsenic Trioxide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 2
    Active Ingredient Units mg/mL
    Substance Name ARSENIC TRIOXIDE
    Labeler Name Cephalon, LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021248
    Listing Certified Through 2024-12-31

    Package

    NDC 63459-0601-06 (63459060106)

    NDC Package Code 63459-601-06
    Billing NDC 63459060106
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (63459-601-06) / 6 mL in 1 VIAL, SINGLE-DOSE (63459-601-11)
    Marketing Start Date 2017-12-22
    NDC Exclude Flag N
    Pricing Information N/A